GoTo Telemed Launches Comprehensive Vitamin B12 Deficiency Management Program

KALISPELL, Mont. - June 3, 2026 - PRLog -- GoTo Telemed, a nationwide integrated telehealth ecosystem serving over 10 million patients, today announced the launch of its dedicated Vitamin B12 Deficiency Management Program, a comprehensive virtual care initiative designed to provide early detection, evidence‑based treatment, and long‑term monitoring for one of the most common—and most overlooked—nutritional deficiencies in the United States. Delivered by a multidisciplinary network of primary care physicians, neurologists, hematologists, registered dietitians, and clinical pharmacists through GoTo Telemed's secure, HIPAA‑compliant platform, the program brings guideline‑aligned B12 care directly into patients' homes across all 50 states.

Vitamin B12 (cobalamin) deficiency is a major public health problem, affecting an estimated 3% to 10% of the general population, with prevalence rising to 20% to 30% among older adults, and up to 40% in certain subgroups such as vegetarians, vegans, patients with gastrointestinal disorders, and individuals taking long‑term acid‑suppressing medications. The consequences are potentially devastating: irreversible neurological damage (subacute combined degeneration of the spinal cord), demyelinating neuropathy, neuropsychiatric syndromes (memory loss, psychosis, depression), and macrocytic anemia. Despite this, deficiency remains underdiagnosed, with many patients experiencing years of unexplained symptoms—fatigue, paresthesias, cognitive slowing—before receiving appropriate evaluation.

"Vitamin B12 deficiency is far more common than most clinicians realize, and the neurological and psychiatric damage can become irreversible if treatment is delayed," said a GoTo Telemed spokesperson. "Our Vitamin B12 Deficiency Management Program changes the paradigm. We integrate at‑home blood spot testing, virtual specialist consultation, personalized supplementation protocols, and long‑term monitoring into a single, unified telehealth platform. By eliminating the barriers of geographic access, specialist shortages, and inconvenient lab visits, we are making evidence‑based B12 care accessible to the millions of Americans who remain undiagnosed or inadequately treated."

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/